3D-QSAR modeling of Phosphodiesterase-5 inhibitors: evaluation and comparison of the receptor- and ligand-based alignments

3D-QSAR modeling of Phosphodiesterase-5 inhibitors: evaluation and comparison of the receptor- and ligand-based alignments
复制标题

磷酸二酯酶 5 抑制剂的 3D-QSAR 建模:基于受体和配体的比对的评估和比较

DOI:
10.1007/s00044-019-02311-x
复制
发表时间:
2019-06
影响因子:
2.6
通讯作者:
Cai Xiong
Cai Xiong
中科院分区:
医学4区
文献类型:
--
作者:
Jiang Zan;Zheng Xuehua;Li Zhong;Pan Shuqiong;Wang Xiaoyu;Zhang Chen;Li Zhe;Luo Hai Bin;Wu Deyan;Cai Xiong

文献摘要

参考文献

相似文献

磷酸二酯酶-5(PDE5)抑制剂可作为治疗勃起功能障碍和肺动脉高压的临床药物。一系列芳基-色烯-吡咯衍生物已被本实验室鉴定为PDE5抑制剂。在此,我们用CoMFA和CoMSIA方法对这些分子进行了3D-QSAR分析,以更深入地了解它们的生物活性的结构要求。使用基于受体和配体的比对方法并进行比较,以找出影响QSAR模型准确性的比对相关因素。基于受体的CoMFA和CoMSIA模型是通过将对接构象直接叠加在蛋白质结合部位而产生的,对38个训练集化合物和5个测试集分子给出了更显著的结果。两种比对结果的比较表明,配体的空间排列是决定3D-QSAR模型可靠性的主要因素。对基于受体的CoMSIA-SE等值线图的详细分析为提高芳基-色烯-吡咯类似物作为PDE5抑制剂的生物活性提供了许多有用的信息。
Phosphodiesterase-5 (PDE5) inhibitors can be used as clinical agents for the treatment of erectile dysfunction and pulmonary hypertension. A series of aryl-chromeno-pyrrol derivatives were previously identified as PDE5 inhibitors in our lab. Herein, these molecules were subjected to 3D-QSAR analysis with CoMFA and CoMSIA methods to gain deeper insight into the structural requirements for their bioactivities. Receptor- and ligand-based alignment were used and compared to find the alignment-related factors that affect the accuracy of QSAR models. The receptor-based CoMFA and CoMSIA models, which were generated by superimposing the docking conformations directly in the protein binding site, gave more significant results for 38 training set compounds and 5 test set molecules. Comparison of the two alignments revealed that spatial arrangement of the ligands is the principal factor in determining the reliability of the 3D-QSAR models. Detailed analysis of the receptor-based CoMSIA-SE contour maps provided much helpful information to improve the bioactivities of aryl-chromeno-pyrrol analogs as PDE5 inhibitors.
DOI: 10.1007/bf02976575
发表时间: 2000-10
影响因子: 6.7
作者:
T. Oh;K. Kang;B. Ahn;M. Yoo;W. Kim
通讯作者: T. Oh;K. Kang;B. Ahn;M. Yoo;W. Kim
DOI: 10.2165/00002512-200219030-00006
发表时间: 2002
期刊: Drugs & Aging
影响因子: 2.8
作者:
H. Porst
通讯作者: H. Porst
DOI: 10.1177/1753465812463627
发表时间: 2013-02
影响因子: 4.3
作者:
Dioma U. Udeoji;E. Schwarz
通讯作者: Dioma U. Udeoji;E. Schwarz
3-(3,4-二氢异喹啉-2(1H)-基磺酰基)苯甲酸作为 AKR1C3 抑制剂的 3D-QSAR 研究:强调分子对接在构象生成中的重要性
DOI: 10.1016/j.bmcl.2016.10.073
发表时间: 2016
影响因子: 2.7
作者:
Xuehua Zheng;Yinuo Wu;Deyan Wu;Xinhua Wang;Chao Zhang;Xiaolei Guo;Hai-Bin Luo
通讯作者: Hai-Bin Luo
DOI: 10.1056/nejmoa050010
发表时间: 2005-11-17
影响因子: 158.5
作者:
Galiè, N;Ghofrani, HA;Simonneau, G
通讯作者: Simonneau, G